nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CYP2D6—Hydroxyurea—psoriasis	0.0927	0.0968	CbGbCtD
Sulfanilamide—CYP2C19—Cholecalciferol—psoriasis	0.0738	0.0772	CbGbCtD
Sulfanilamide—CYP3A4—Calcitriol—psoriasis	0.0693	0.0724	CbGbCtD
Sulfanilamide—CYP2C9—Cholecalciferol—psoriasis	0.0614	0.0642	CbGbCtD
Sulfanilamide—CYP2D6—Cholecalciferol—psoriasis	0.0561	0.0587	CbGbCtD
Sulfanilamide—CYP3A4—Methoxsalen—psoriasis	0.0539	0.0563	CbGbCtD
Sulfanilamide—CYP2C19—Prednisone—psoriasis	0.0512	0.0535	CbGbCtD
Sulfanilamide—CYP2E1—Dexamethasone—psoriasis	0.051	0.0533	CbGbCtD
Sulfanilamide—CYP2C19—Cyclosporine—psoriasis	0.0485	0.0507	CbGbCtD
Sulfanilamide—CYP2C9—Cyclosporine—psoriasis	0.0403	0.0422	CbGbCtD
Sulfanilamide—CYP2D6—Cyclosporine—psoriasis	0.0369	0.0386	CbGbCtD
Sulfanilamide—CYP3A4—Cholecalciferol—psoriasis	0.0357	0.0373	CbGbCtD
Sulfanilamide—CYP2C19—Dexamethasone—psoriasis	0.032	0.0334	CbGbCtD
Sulfanilamide—CYP3A4—Mycophenolate mofetil—psoriasis	0.031	0.0323	CbGbCtD
Sulfanilamide—CYP3A4—Triamcinolone—psoriasis	0.031	0.0323	CbGbCtD
Sulfanilamide—CYP2C9—Dexamethasone—psoriasis	0.0266	0.0278	CbGbCtD
Sulfanilamide—CYP3A4—Betamethasone—psoriasis	0.0266	0.0278	CbGbCtD
Sulfanilamide—CYP3A4—Prednisolone—psoriasis	0.0262	0.0274	CbGbCtD
Sulfanilamide—CYP3A4—Hydrocortisone—psoriasis	0.0248	0.026	CbGbCtD
Sulfanilamide—CYP3A4—Prednisone—psoriasis	0.0247	0.0259	CbGbCtD
Sulfanilamide—CYP2D6—Dexamethasone—psoriasis	0.0243	0.0254	CbGbCtD
Sulfanilamide—CYP3A4—Cyclosporine—psoriasis	0.0235	0.0245	CbGbCtD
Sulfanilamide—CYP3A4—Dexamethasone—psoriasis	0.0154	0.0161	CbGbCtD
Sulfanilamide—Burning sensation—Tazarotene—psoriasis	0.00472	0.368	CcSEcCtD
Sulfanilamide—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00222	0.0731	CbGpPWpGaD
Sulfanilamide—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00171	0.0564	CbGpPWpGaD
Sulfanilamide—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00157	0.0518	CbGpPWpGaD
Sulfanilamide—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00156	0.0514	CbGpPWpGaD
Sulfanilamide—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00147	0.0484	CbGpPWpGaD
Sulfanilamide—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00137	0.0453	CbGpPWpGaD
Sulfanilamide—Discomfort—Tazarotene—psoriasis	0.00121	0.094	CcSEcCtD
Sulfanilamide—Burning sensation—Cyclosporine—psoriasis	0.0012	0.0936	CcSEcCtD
Sulfanilamide—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00106	0.0349	CbGpPWpGaD
Sulfanilamide—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000975	0.0321	CbGpPWpGaD
Sulfanilamide—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000967	0.0319	CbGpPWpGaD
Sulfanilamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—psoriasis	0.000903	0.0298	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—CP—psoriasis	0.000746	0.0246	CbGpPWpGaD
Sulfanilamide—Discomfort—Methoxsalen—psoriasis	0.000728	0.0567	CcSEcCtD
Sulfanilamide—Burning sensation—Methotrexate—psoriasis	0.000665	0.0517	CcSEcCtD
Sulfanilamide—Discomfort—Calcitriol—psoriasis	0.000649	0.0506	CcSEcCtD
Sulfanilamide—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000637	0.021	CbGpPWpGaD
Sulfanilamide—Discomfort—Acitretin—psoriasis	0.000577	0.045	CcSEcCtD
Sulfanilamide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000571	0.0188	CbGpPWpGaD
Sulfanilamide—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000563	0.0186	CbGpPWpGaD
Sulfanilamide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000462	0.0152	CbGpPWpGaD
Sulfanilamide—Discomfort—Hydroxyurea—psoriasis	0.000453	0.0353	CcSEcCtD
Sulfanilamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00044	0.0145	CbGpPWpGaD
Sulfanilamide—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000434	0.0143	CbGpPWpGaD
Sulfanilamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000405	0.0133	CbGpPWpGaD
Sulfanilamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000401	0.0132	CbGpPWpGaD
Sulfanilamide—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.0004	0.0132	CbGpPWpGaD
Sulfanilamide—CA9—Cellular response to hypoxia—VEGFA—psoriasis	0.000399	0.0132	CbGpPWpGaD
Sulfanilamide—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000396	0.0131	CbGpPWpGaD
Sulfanilamide—Discomfort—Mycophenolic acid—psoriasis	0.00038	0.0296	CcSEcCtD
Sulfanilamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000357	0.0118	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—LEP—psoriasis	0.00034	0.0112	CbGpPWpGaD
Sulfanilamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000328	0.0108	CbGpPWpGaD
Sulfanilamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000325	0.0107	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000317	0.0104	CbGpPWpGaD
Sulfanilamide—Discomfort—Cyclosporine—psoriasis	0.000307	0.0239	CcSEcCtD
Sulfanilamide—Discomfort—Mycophenolate mofetil—psoriasis	0.0003	0.0233	CcSEcCtD
Sulfanilamide—Discomfort—Prednisolone—psoriasis	0.00028	0.0218	CcSEcCtD
Sulfanilamide—Discomfort—Hydrocortisone—psoriasis	0.000273	0.0213	CcSEcCtD
Sulfanilamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000265	0.00872	CbGpPWpGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000262	0.00864	CbGpPWpGaD
Sulfanilamide—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000261	0.00861	CbGpPWpGaD
Sulfanilamide—Discomfort—Triamcinolone—psoriasis	0.000257	0.02	CcSEcCtD
Sulfanilamide—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000246	0.0081	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—NDUFA5—psoriasis	0.000244	0.00805	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000242	0.00799	CbGpPWpGaD
Sulfanilamide—Discomfort—Dexamethasone—psoriasis	0.000233	0.0182	CcSEcCtD
Sulfanilamide—Discomfort—Betamethasone—psoriasis	0.000233	0.0182	CcSEcCtD
Sulfanilamide—CA7—Metabolism—NDUFA5—psoriasis	0.000228	0.00752	CbGpPWpGaD
Sulfanilamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000215	0.00707	CbGpPWpGaD
Sulfanilamide—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000212	0.00699	CbGpPWpGaD
Sulfanilamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000212	0.00698	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—NDUFA5—psoriasis	0.000211	0.00697	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—JUN—psoriasis	0.00021	0.00692	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CYP2S1—psoriasis	0.000208	0.00685	CbGpPWpGaD
Sulfanilamide—Discomfort—Prednisone—psoriasis	0.000203	0.0158	CcSEcCtD
Sulfanilamide—CA7—Metabolism—CYP2S1—psoriasis	0.000194	0.00639	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.00019	0.00625	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000187	0.00616	CbGpPWpGaD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000184	0.00608	CbGpPWpGaD
Sulfanilamide—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000184	0.00606	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.000184	0.00605	CbGpPWpGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000183	0.00602	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—CYP2S1—psoriasis	0.00018	0.00592	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000174	0.00575	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000173	0.0057	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000172	0.00567	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.00017	0.00562	CbGpPWpGaD
Sulfanilamide—Discomfort—Methotrexate—psoriasis	0.00017	0.0132	CcSEcCtD
Sulfanilamide—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000169	0.00557	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—NDUFA5—psoriasis	0.000162	0.00533	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—CAT—psoriasis	0.000144	0.00476	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CYP2S1—psoriasis	0.000137	0.00453	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—NDUFA5—psoriasis	0.000136	0.00449	CbGpPWpGaD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000129	0.00424	CbGpPWpGaD
Sulfanilamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000122	0.00401	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CYP2S1—psoriasis	0.000116	0.00382	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000114	0.00376	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000112	0.00371	CbGpPWpGaD
Sulfanilamide—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000109	0.0036	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CARM1—psoriasis	0.000101	0.00334	CbGpPWpGaD
Sulfanilamide—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000101	0.00331	CbGpPWpGaD
Sulfanilamide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.83e-05	0.00324	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—CARM1—psoriasis	9.47e-05	0.00312	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—CARM1—psoriasis	8.78e-05	0.00289	CbGpPWpGaD
Sulfanilamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.48e-05	0.00279	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—CXCL8—psoriasis	7.45e-05	0.00246	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—JUN—psoriasis	6.93e-05	0.00228	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CARM1—psoriasis	6.71e-05	0.00221	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—NFKB1—psoriasis	6.67e-05	0.0022	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CAT—psoriasis	6.24e-05	0.00206	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—VEGFA—psoriasis	6.05e-05	0.002	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—STAT3—psoriasis	5.99e-05	0.00198	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—CAT—psoriasis	5.83e-05	0.00192	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CARM1—psoriasis	5.65e-05	0.00186	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—CAT—psoriasis	5.4e-05	0.00178	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NDUFA5—psoriasis	4.94e-05	0.00163	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—APOE—psoriasis	4.85e-05	0.0016	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—TP53—psoriasis	4.57e-05	0.00151	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—APOE—psoriasis	4.53e-05	0.00149	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PPARG—psoriasis	4.22e-05	0.00139	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP2S1—psoriasis	4.2e-05	0.00138	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—APOE—psoriasis	4.19e-05	0.00138	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—IL6—psoriasis	4.19e-05	0.00138	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CAT—psoriasis	4.13e-05	0.00136	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PPARG—psoriasis	3.94e-05	0.0013	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NDUFA5—psoriasis	3.81e-05	0.00126	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PPARG—psoriasis	3.65e-05	0.0012	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.55e-05	0.00117	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NDUFA5—psoriasis	3.51e-05	0.00116	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CAT—psoriasis	3.48e-05	0.00115	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NDUFA5—psoriasis	3.48e-05	0.00115	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP2S1—psoriasis	3.24e-05	0.00107	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.24e-05	0.00107	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—APOE—psoriasis	3.21e-05	0.00106	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYP2S1—psoriasis	2.98e-05	0.000983	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP2S1—psoriasis	2.96e-05	0.000974	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PPARG—psoriasis	2.79e-05	0.00092	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—APOE—psoriasis	2.7e-05	0.000891	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PPARG—psoriasis	2.35e-05	0.000776	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NDUFA5—psoriasis	2.29e-05	0.000756	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CARM1—psoriasis	2.05e-05	0.000676	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP2S1—psoriasis	1.95e-05	0.000642	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.7e-05	0.00056	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CARM1—psoriasis	1.58e-05	0.000522	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.55e-05	0.000511	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.48e-05	0.000488	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CARM1—psoriasis	1.46e-05	0.00048	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CARM1—psoriasis	1.44e-05	0.000476	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.35e-05	0.000445	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CAT—psoriasis	1.26e-05	0.000416	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—APOE—psoriasis	9.81e-06	0.000323	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CAT—psoriasis	9.74e-06	0.000321	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CARM1—psoriasis	9.52e-06	0.000314	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CAT—psoriasis	8.96e-06	0.000295	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CAT—psoriasis	8.88e-06	0.000293	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PPARG—psoriasis	8.54e-06	0.000282	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—APOE—psoriasis	7.57e-06	0.000249	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—APOE—psoriasis	6.96e-06	0.000229	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—APOE—psoriasis	6.9e-06	0.000227	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PPARG—psoriasis	6.59e-06	0.000217	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PPARG—psoriasis	6.06e-06	0.0002	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PPARG—psoriasis	6.01e-06	0.000198	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CAT—psoriasis	5.86e-06	0.000193	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—APOE—psoriasis	4.55e-06	0.00015	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PPARG—psoriasis	3.96e-06	0.000131	CbGpPWpGaD
